Skip to main content

Animations

MJFF Publications

4311 - 4320 of 8471 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • Summary Details
    RESTRICTED
    Title: Approaches to Disease Modification for Parkinson’s Disease: Clinical Trials and Lessons Learned
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-020-00964-w
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Association of caffeine and related analytes with resistance to Parkinson disease among LRRK2 mutation carriers
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000010863
    Citation Count: 48
  • Summary Details
    OPEN
    Title: BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1007/s13311-020-00965-9
    Citation Count: 17
  • Summary Details
    RESTRICTED
    Title: Characteristics, treatment patterns and disease burden of people with Parkinson's disease in the Parkinson's disease real-world impact assessment (PRISM) study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.312
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Comparison of Patient and Expert Perceptions of the Attainment of Research Milestones in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28319
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Complementary Therapies in Parkinson Disease: a Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and Cannabis
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-020-00900-y
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Comprehensive Analysis of Familial Parkinsonism Genes in Rapid‐Eye‐Movement Sleep Behavior Disorder
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28318
    Citation Count: 13
  • Summary Details
    RESTRICTED
    Title: Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-020-00914-6
    Citation Count: 58
  • Summary Details
    RESTRICTED
    Title: Detecting bradykinesia in early morning “OFF” episodes: a large database study using the Personal KinetiGraph® (PKG®)
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.322
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Differences in the Presentation and Progression of Parkinson's Disease by Sex
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28312
    Citation Count: 66
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.